Correlation Between Purple Biotech and BioLine RX

Can any of the company-specific risk be diversified away by investing in both Purple Biotech and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Purple Biotech and BioLine RX, you can compare the effects of market volatilities on Purple Biotech and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and BioLine RX.

Diversification Opportunities for Purple Biotech and BioLine RX

-0.54

Correlation Coefficient

Purple Biotech  BioLine RX

Excellent diversification

The 3 months correlation between Purple and BioLine is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Purple Biotech i.e., Purple Biotech and BioLine RX go up and down completely randomly.

Pair Corralation between Purple Biotech and BioLine RX

Assuming the 90 days trading horizon Purple Biotech is expected to under-perform the BioLine RX. But the stock apears to be less risky and, when comparing its historical volatility, Purple Biotech is 1.97 times less risky than BioLine RX. The stock trades about -0.04 of its potential returns per unit of risk. The BioLine RX is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  180.00  in BioLine RX on April 24, 2025 and sell it today you would earn a total of  80.00  from holding BioLine RX or generate 44.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	97.96%
Values	Daily Returns

Purple Biotech  vs.  BioLine RX

Purple Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

BioLine RX

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BioLine RX are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BioLine RX sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Purple Biotech and BioLine RX

The main advantage of trading using opposite Purple Biotech and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.

The idea behind Purple Biotech and BioLine RX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.